Thonzylamine
Top View
- (12) United States Patent (10) Patent No.: US 8,882,729 B2 Horstmann Et Al
- (HMO SNP) Non-Part D and Over the Counter Medicaid Covered Drugs
- 207768Orig1s000
- Alphabetical Listing by Therapeutic Category Dod UNIFORM
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Npgrj NCHEMBIO 806 415..416
- (12) Patent Application Publication (10) Pub. No.: US 2017/0020873 A1 Mitchell (43) Pub
- Prevalence of Psychoactive Substances in the General Population
- Pharmaabkommen A1 E
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- Customs Tariff - Schedule Xxi - 1
- 243 Subpart B—Active Ingredients
- Thonzylamine Hydrochloride/Tritoqualine
- Ownloaded from Ascelibrary.Org by New York University on 02/16/15
- 201373Orig1s000
- Histamine H1-Receptor Antagonists: Antihistaminic Agents